CIM
MIRM icon

Contravisory Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Contravisory Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Buy
4,604
+103
+2% +$10.3K 0.1% 147
2026
Q1 		$416K Sell
4,501
-434
-9% -$40.8K 0.09% 151
2025
Q4 		$390K Sell
4,935
-192
-4% -$13.8K 0.08% 165
2025
Q3 		$376K Sell
5,127
-180
-3% -$11.4K 0.07% 182
2025
Q2 		$270K Buy
+5,307
New +$236K 0.05% 210

Other funds holding MIRM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Contravisory Investment Management's MIRM Position: Q2 2026 in Review

Contravisory Investment Management increased its Mirum Pharmaceuticals (MIRM) stake by 2.3% in Q2 2026, buying an estimated $10.3K and bringing the position to 4,604 shares worth $539K. The position accounts for 0.1% of the portfolio, ranked #147.

Contravisory Investment Management first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Contravisory Investment Management held 4,604 shares of Mirum Pharmaceuticals worth $539K as of Q2 2026.
  • Contravisory Investment Management bought 103 Mirum Pharmaceuticals shares in Q2 2026, an estimated $10.3K.
  • Mirum Pharmaceuticals made up 0.1% of Contravisory Investment Management's portfolio in Q2 2026, its #147 holding.
  • Contravisory Investment Management first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.